Sartorius Stedim Biotech (SDMHF) Short Interest Ratio & Short Volume $216.65 -6.67 (-2.99%) As of 05/30/2025 03:33 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartHeadlinesShort InterestBuy This Stock Sartorius Stedim Biotech Short Interest DataSartorius Stedim Biotech (SDMHF) has a short interest of 35,300 shares. This marks a 23.43% increase in short interest from the previous month. The short interest ratio (days to cover) is 32.1, indicating that it would take 32.1 days of the average trading volume of 2,788 shares to cover all short positions.Current Short Interest35,300 sharesPrevious Short Interest28,600 sharesChange Vs. Previous Month+23.43%Dollar Volume Sold Short$7.80 millionShort Interest Ratio32.1 Days to CoverLast Record DateMay 15, 2025Today's Trading Volume1,276 sharesAverage Trading Volume2,788 sharesToday's Volume Vs. Average46% Short Selling Sartorius Stedim Biotech? Sign up to receive the latest short interest report for Sartorius Stedim Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSDMHF Short Interest Over TimeSDMHF Days to Cover Over TimeSDMHF Percentage of Float Shorted Over Time Sartorius Stedim Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202535,300 shares $7.80 million +23.4%N/A32.1 $221.00 4/30/202528,600 shares $6.66 million +8.3%N/A0 $233.00 4/15/202526,400 shares $5.17 million +118.2%N/A2.7 $195.68 3/31/202512,100 shares $2.47 million +45.8%N/A7.1 $204.04 3/15/20258,300 shares $1.75 million -23.9%N/A1.3 $210.46 2/28/202510,900 shares $2.27 million -64.7%N/A1.9 $208.00 2/15/202530,900 shares $6.75 million -18.5%N/A309 $218.50 1/31/202537,900 shares $8.96 million -23.0%N/A6 $236.50 1/15/202549,200 shares $10.18 million -19.1%N/A70.3 $207.00 12/31/202460,800 shares $11.86 million +5.7%N/A202.7 $195.00 Get the Latest News and Ratings for SDMHF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sartorius Stedim Biotech and its competitors with MarketBeat's FREE daily newsletter. 12/15/202457,500 shares $11.45 million -19.4%N/A575 $199.20 11/30/202471,300 shares $12.56 million +34.0%N/A7.6 $176.10 11/15/202453,200 shares $9.83 million -33.3%N/A266 $184.69 10/31/202479,800 shares $16.03 million -5.0%N/A66.5 $200.89 10/15/202484,000 shares $16.77 million +12.8%N/A28 $199.62 9/30/202474,500 shares $15.87 million -22.2%N/A248.3 $213.00 9/15/202495,700 shares $19.23 million +21.3%N/A957 $200.90 8/31/202478,900 shares $16.31 million +0.8%N/A789 $206.70 8/15/202478,300 shares $14.73 million +20.5%N/A41.2 $188.18 7/31/202465,000 shares $10.40 million +39.2%N/A7.4 $160.00 7/15/202446,700 shares $8.23 million +0.7%N/A66.7 $176.20 6/30/202446,400 shares $7.66 million -25.5%N/A4.5 $165.00 6/15/202462,300 shares $11.84 million +34.0%N/A32.8 $190.00 5/31/202446,500 shares $9.77 million +0.9%N/A9.7 $210.00 5/15/202446,100 shares $10.57 million +28.4%N/A9.4 $229.31 4/30/202435,900 shares $7.90 million +4.4%N/A179.5 $220.00 4/15/202434,400 shares $9.29 million +78.2%N/A68.8 $270.00 3/31/202419,300 shares $5.39 million +7.2%N/A193 $279.50 3/15/202418,000 shares $5.32 million +9.1%N/A180 $295.61 2/29/202416,500 shares $4.39 million -6.8%N/A165 $266.00 2/15/202417,700 shares $4.64 million +5.4%N/A177 $262.24 1/15/202420,200 shares $5.13 million -21.7%N/A202 $254.00 12/31/202325,800 shares $6.80 million -15.7%N/A314.9 $263.75 12/15/202330,600 shares $7.54 million +22.9%N/A306 $246.30 11/30/202324,900 shares $5.28 million -31.0%N/A249 $212.00 11/15/202336,100 shares $7.28 million +60.4%N/A120.3 $201.75 10/31/202322,500 shares $4.16 million +7.1%N/A2 $185.10 10/15/202321,000 shares $4.12 million -11.0%N/A210 $196.15 9/30/202323,600 shares $5.51 million -1.3%N/A236 $233.46 9/15/202323,900 shares $6.82 million -8.4%N/A239 $285.40The “supermetal” that could power AI (Ad)While the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the story. This next-gen supermetal, dubbed “black glass,” could solve the power crisis stalling AI’s growth. It’s 400x stronger than steel, conducts electricity better than copper, and costs just a few bucks to produce.The AI bottleneck no one’s talking about — until now 8/31/202326,100 shares $6.95 million +3.2%N/A511.9 $266.19 8/15/202325,300 shares $7.35 million +13.5%N/A253 $290.40 7/31/202322,300 shares $6.86 million +3.7%N/A223 $307.70 7/15/202321,500 shares $5.60 million No ChangeN/A215 $260.54 6/30/202321,500 shares $5.25 million +3.4%N/A16.5 $244.33 6/15/202320,800 shares $6.18 million -0.5%N/A208 $297.35 5/31/202320,900 shares $5.56 million +5.0%N/A34.8 $265.80 5/15/202319,900 shares $5.48 million -3.9%N/A199 $275.40 4/30/202320,700 shares $5.51 million +25.5%N/A29.6 $266.10 4/15/202316,500 shares $5.16 million -47.0%N/A165 $312.50 3/31/202331,100 shares $9.98 million +88.5%N/A311 $321.00 3/15/202316,500 shares $5.89 million +1.2%N/A165 $357.00 2/28/202316,300 shares $5.82 million +0.6%N/A163 $357.00 2/15/202316,200 shares $6.13 million -37.5%N/A54 $378.65 1/31/202325,900 shares $8.60 million +0.4%N/A259 $332.10 1/15/202325,800 shares $8.49 million -5.5%N/A0 $328.96 12/30/202227,300 shares $8.98 million -0.4%N/A273 $328.96 12/15/202227,400 shares $9.67 million +2.6%N/A274 $353.00 11/30/202226,700 shares $8.37 million -46.9%N/A267 $313.60 11/15/202250,300 shares $15.77 million +18.1%N/A0 $313.60 10/31/202242,600 shares $12.97 million +163.0%N/A426 $304.54 10/15/202216,200 shares $5.32 million +0.6%N/A162 $328.30 9/30/202216,100 shares $5.04 million +2.6%N/A161 $313.35 9/15/202215,700 shares $5.88 million -0.6%N/A157 $374.55 8/31/202215,800 shares $5.55 million -26.2%N/A0 $351.00 8/15/202221,400 shares $7.51 million -64.5%N/A214 $351.00 7/31/202260,300 shares $21.17 million +9.4%N/A603 $351.00 7/15/202255,100 shares $18.16 million No ChangeN/A275.5 $329.50 6/30/202255,100 shares $16.73 million -0.9%N/A275.5 $303.64 6/15/202255,600 shares $16.97 million -0.2%N/A556 $305.24 5/31/202255,700 shares $19.52 million -2.5%N/A185.7 $350.49 5/15/202257,100 shares $17.80 million +9.2%N/A142.8 $311.74 4/30/202252,300 shares $16.45 million -0.2%N/A87.2 $314.50 4/15/202252,400 shares $19.51 million No ChangeN/A0 $372.25 3/31/202252,400 shares $20.78 million +3.0%N/A524 $396.55 3/15/202250,900 shares $17.72 million -2.1%N/A509 $348.10 2/28/202252,000 shares $19.60 million -0.2%N/A520 $376.99 2/15/202252,100 shares $21.08 million No ChangeN/A521 $404.66 1/31/202252,100 shares $22.58 million +2.6%N/A260.5 $433.43 1/15/202250,800 shares $21.84 million +9.5%N/A508 $429.99 12/31/202146,400 shares $25.80 million +0.2%N/A77.3 $556.00 12/15/202146,300 shares $23.97 million -0.2%N/A463 $517.75 11/30/202146,400 shares $24.85 million +0.2%N/A464 $535.64 11/15/202146,300 shares $24.33 million +0.2%N/A231.5 $525.41 10/29/202146,200 shares $25.57 million +0.2%N/A231 $553.39 10/15/202146,100 shares $23.05 million No ChangeN/A461 $500.00 9/30/202146,100 shares $27.11 million -3.0%N/A461 $588.00 9/15/202147,500 shares $29.74 million -0.6%N/A475 $626.05 8/31/202147,800 shares $29.40 million -1.0%N/A478 $615.00 8/13/202148,300 shares $27.28 million -6.4%N/A483 $564.70The “supermetal” that could power AI (Ad)While the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the story. This next-gen supermetal, dubbed “black glass,” could solve the power crisis stalling AI’s growth. It’s 400x stronger than steel, conducts electricity better than copper, and costs just a few bucks to produce.The AI bottleneck no one’s talking about — until now 7/30/202151,600 shares $29.58 million +1.6%N/A516 $573.25 7/15/202150,800 shares $24.90 million +1.2%N/A508 $490.08 6/30/202150,200 shares $23.49 million +1.4%N/A502 $468.00 6/15/202149,500 shares $21.52 million +4.4%N/A495 $434.78 5/28/202147,400 shares $20.61 million +1.5%N/A474 $434.78 5/14/202146,700 shares $20.86 million -0.4%N/A467 $446.73 4/30/202146,900 shares $21.33 million +0.6%N/A469 $454.75 4/15/202146,600 shares $20.13 million -3.9%N/A466 $431.95 3/31/202148,500 shares $19.61 million +8.3%N/A0 $404.30 3/15/202144,800 shares $17.96 million +1.6%N/A448 $401.00 2/26/202144,100 shares $19.58 million +3.3%N/A441 $444.00 2/12/202142,700 shares $20.42 million -0.2%N/A427 $478.20 1/29/202142,800 shares $17.25 million -9.5%N/A428 $403.00 1/15/202143,800 shares $16.08 million +2.6%N/A438 $367.20 12/31/202044,700 shares $16.26 million +2.1%N/A447 $363.80 12/15/202043,800 shares $15.61 million +2.6%N/A438 $356.40 11/30/202042,700 shares $14.43 million +8.9%N/A427 $337.90 11/15/202039,200 shares $14.83 million -0.5%N/A392 $378.25 10/30/202039,400 shares $15.04 million +2.1%N/A394 $381.80 10/15/202038,600 shares $13.52 million -0.3%N/A386 $350.30 9/30/202038,700 shares $13.18 million No ChangeN/A387 $340.45 9/15/202038,700 shares $13.82 million No ChangeN/A387 $357.15 8/31/202038,700 shares $13.52 million -0.3%N/A387 $349.40 8/14/202038,800 shares $12.03 million +0.5%N/A0 $310.00 7/31/202038,600 shares $11.80 million -1.0%N/A386 $305.75 7/15/202039,000 shares $10.92 million -2.0%N/A390 $279.95 6/30/202039,800 shares $9.90 million +2.6%N/A398 $248.75 6/15/202038,800 shares $9.18 million -0.3%N/A194 $236.70 SDMHF Short Interest - Frequently Asked Questions What is Sartorius Stedim Biotech's current short interest? Short interest is the volume of Sartorius Stedim Biotech shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 35,300 shares of SDMHF short. Learn More on Sartorius Stedim Biotech's current short interest. What is a good short interest ratio for Sartorius Stedim Biotech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SDMHF shares currently have a short interest ratio of 32.0. Learn More on Sartorius Stedim Biotech's short interest ratio. Is Sartorius Stedim Biotech's short interest increasing or decreasing? Sartorius Stedim Biotech saw a increase in short interest in May. As of May 15th, there was short interest totaling 35,300 shares, an increase of 23.4% from the previous total of 28,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Sartorius Stedim Biotech's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Sartorius Stedim Biotech: Straumann Holding AG (1.28%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks. What does it mean to sell short Sartorius Stedim Biotech stock? Short selling SDMHF is an investing strategy that aims to generate trading profit from Sartorius Stedim Biotech as its price is falling. SDMHF shares are trading down $6.67 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sartorius Stedim Biotech? A short squeeze for Sartorius Stedim Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SDMHF, which in turn drives the price of the stock up even further. How often is Sartorius Stedim Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SDMHF, twice per month. The most recent reporting period available is May, 15 2025. More Short Interest Resources from MarketBeat Related Companies ADDLF Short Squeeze ANSLY Short Squeeze ANSLF Short Squeeze BITGF Short Squeeze CZMWY Short Squeeze CLPBF Short Squeeze CNVVY Short Squeeze ESLOF Short Squeeze FLMNY Short Squeeze FLMNF Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:SDMHF) was last updated on 6/1/2025 by MarketBeat.com Staff From Our PartnersTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredBanks aren’t ready for this altcoin—are you?I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredThe “supermetal” that could power AIWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Buffett Indicator is screaming, “sell stocks, buy gold”A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sartorius Stedim Biotech S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sartorius Stedim Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SDMHF Stock Free SDMHF Stock Alerts